MDT

83.96

-3.15%↓

A

122.11

+1.16%↑

VEEV

167.88

-0.39%↓

HQY

85.4

-0.51%↓

NEOG

9.54

-0.42%↓

MDT

83.96

-3.15%↓

A

122.11

+1.16%↑

VEEV

167.88

-0.39%↓

HQY

85.4

-0.51%↓

NEOG

9.54

-0.42%↓

MDT

83.96

-3.15%↓

A

122.11

+1.16%↑

VEEV

167.88

-0.39%↓

HQY

85.4

-0.51%↓

NEOG

9.54

-0.42%↓

MDT

83.96

-3.15%↓

A

122.11

+1.16%↑

VEEV

167.88

-0.39%↓

HQY

85.4

-0.51%↓

NEOG

9.54

-0.42%↓

MDT

83.96

-3.15%↓

A

122.11

+1.16%↑

VEEV

167.88

-0.39%↓

HQY

85.4

-0.51%↓

NEOG

9.54

-0.42%↓

Начало・Списък с акции・Ardelyx Inc

Search

Ardelyx Inc

Отворен

СекторЗдравеопазване

6.19 -2.83

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

6.17

Максимум

6.38

Ключови измерители
By Trading Economics
Приходи	562K -407K
Продажби	15M 125M
EPS	-0.002
Марж на печалбата	-0.325
Служители	489
EBITDA	4.5M 10M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+153.18% upside

Дивиденти
By Dow Jones
Следващи печалби	30.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-117M 1.6B
Предишно отваряне	9.02
Предишно затваряне	6.19

Настроения в новините

By Acuity

13%

87%

21 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

3.62 / 3.95 Подкрепа & съпротива

Ardelyx Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.04.2026 г., 23:49 ч. UTC

Значими събития в новините

New Zealand 1Q Inflation Higher Than Expected

20.04.2026 г., 23:10 ч. UTC

Горещи акции

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20.04.2026 г., 22:53 ч. UTC

Значими двигатели на пазара

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20.04.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20.04.2026 г., 23:44 ч. UTC

Пазарно говорене

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20.04.2026 г., 23:39 ч. UTC

Пазарно говорене

Rio Tinto Posts Strong Start to Year -- Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20.04.2026 г., 23:09 ч. UTC

Пазарно говорене

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20.04.2026 г., 22:31 ч. UTC

Придобивния, сливания и поглъщания

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20.04.2026 г., 22:26 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Aims for Acquisition to Be Completed by End-2026

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Acquisition Would Be for A$175 Million

20.04.2026 г., 22:24 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20.04.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20.04.2026 г., 22:01 ч. UTC

Придобивния, сливания и поглъщания

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20.04.2026 г., 21:38 ч. UTC

Пазарно говорене

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20.04.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20.04.2026 г., 21:24 ч. UTC

Пазарно говорене

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20.04.2026 г., 21:24 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.04.2026 г., 21:13 ч. UTC

Печалби

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20.04.2026 г., 21:10 ч. UTC

Печалби

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20.04.2026 г., 21:09 ч. UTC

Печалби

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20.04.2026 г., 21:08 ч. UTC

Печалби

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20.04.2026 г., 21:07 ч. UTC

Печалби

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20.04.2026 г., 21:05 ч. UTC

Печалби

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20.04.2026 г., 21:05 ч. UTC

Печалби

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Сравнение с други в отрасъла

Ценова промяна

Ardelyx Inc Прогноза

Ценова цел

By TipRanks

153.18% нагоре

12-месечна прогноза

Среден 16.33 USD 153.18%

Висок 19 USD

Нисък 13 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Ardelyx Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

6

Купи

0

Задържане

0

Продай

Според 6 анализатори, дали борсови рейтинги на Ardelyx Inc през последните 3 месеца.

Техническа оценка

By Trading Central

3.62 / 3.95Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Настроение

By Acuity

21 / 348 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Ardelyx Inc

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Други акции от сектора

MDT

Medtronic PLC

83.96

A

Agilent Technologies Inc

122.11

VEEV

Veeva Systems Inc

167.88

HQY

HealthEquity Inc

85.4

NEOG

Neogen Corp

9.54

Live chat